Advisory Board and Editors Cell Biology
Consolato Sergi
Dr. Consolato M. Sergi is Chief of Anatomical Pathology of the Children's Hospital of Eastern Ontario, University of Ottawa, Ontario, Canada and Emeritus Professor of Pathology and Pediatrics of the University of Alberta, Canada. Dr. Sergi was born in Rome (Italy), obtained his MD degree with honors at the University of Genoa, Italy, his Human Pathology degree at the University of Heidelberg, Germany, the title of the hon. Clinical Reader of the University of Bristol, UK, his Ph.D./Habilitation at the University of Innsbruck, Austria, his MSc Public Health in Austria, and his FRCPC degree at the Royal College in Ottawa. Dr. Sergi’s specialty areas of interest are congenital heart disease and metabolic diseases, obstructive cholangiopathies, carcinogenesis (bone/soft tissue/liver), gut microbiome, and mitochondrial DNA related cardiomyopathies.
Arif J Siddiqui
Dr. Arif Jamal Siddiqui is an Associate Professor and Principal Investigator at the Department of Biology, College of Science, University of Hail, Saudi Arabia. He received his PhD from CSIR-Central Drug Research Institute, Lucknow, India in 2015. From 2015 to 2018, he worked as a Post-Doctoral Fellow at Texas Tech University Health Sciences Center, Lubbock, Texas, United States of America.
He has more than 8 years of experience in research, teaching and administration. In his professional work, he has received research grants as a Principal Investigator from various renowned organizations. He has successfully published more than 100 publications in internationally recognized peer-reviewed prestigious journals, published several book chapters for internationally renowned publishers and presented many articles and posters in various conferences/workshops worldwide. He has published numerous papers in the fields of parasitology, immunology, herbal medicine, vaccine development, drug discovery and natural products with a specialization in anti-parasitic, antiviral, anticancer and antibacterial agents. Furthermore, he is a member of The Indian Science Congress Association, India and the Annals of Parasitology, Poland. He has reviewed more than 250 manuscripts and he also currently holds various editorial positions (Academic, Associate, Guest and Review Editor) in various reputable journals and has edited more than 150 manuscripts.
Jeremy A. Simpson
Assistant Professor, University of Guelph. Editorial board, Frontiers in Respiratory Physiology
Amit Singh
Dr. Singh received his B.Sc. from the Government Degree College Nahan, H.P. University, India and his M.Sc. and Ph.D from Devi Ahilya University, Indore, India. After a short stint as a Research Associate in the field of Trangenics of silkworm, Bombyx mori, in Indian Institute of Sciences (IISc.), Bangalore, India, Dr. Singh moved to Academic Sinica Taiwan to pursue post doctoral research in the field of eye development using Drosophila melanogaster model system. In 2002, Dr. Singh moved to Baylor College of Medicine, Houston, Texas to further pursue his work on Drosophila eye development and was promoted to an instructor (non-tenure track faculty) position in 2004. Dr. Singh was hired at University of Dayton as a tenure track assistant professor in 2007 and promoted to associate professor in 2013. To date, he has published one book and 52 papers.
Rajesh Kumar Singh
Dr. Rajesh Kumar Singh received his BPharm (2003) and MPharm (2005) from UIPS, Panjab University, Chandigarh. He started to teach pharmaceutical chemistry at the Shivalik College of Pharmacy, Nangal, in 2006, where he completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar. His major areas of research interest are computer-aided drug-design, polymer-drug conjugates for targeted delivery to CNS and cancerous cells, antimalarial therapeutic agents, and green chemistry approaches for chemical synthesis. Dr. Singh has over 15 years of teaching experience and has guided one 03 Ph.D. and 20 PG students. He is currently guiding 02 PhDs and 02 MPharm students. He has published more than 70 peer-reviewed SCI/SCOPUS-indexed scientific papers with a total JCR Impact Factor of more than 200 in various chemistry and pharmacy journals such as European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica-B, Bioorganic Chemistry, Biomedicine and Pharmacotherapy, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Mini-Reviews in Medicinal Chemistry, Pharmaceutical Research, Med. Chem. Res., J. Enzyme Inhi. Med Chem., Res. Chem. Intermediate etc as main or corresponding author. He currently serves as an Editorial Advisory Board Member of 10 international journals, including the SCI-indexed MRMC (Bentham) and PeerJ. He has received the Publon Award 2016, 2017 and the Publon "Excellent Peer Reviewer Award" for outstanding reviewing of more than 290 research papers in different international journals of ACS, RSC, Springer, Elsevier, Dove, Informa, and Bentham whose Impact Factor varies from 1.0 to 12.5. He also has over 60 National and International Conference Abstracts, 5 Books, 5 Best Paper Presentation Awards, 1 Travel Grant to attend International Conferences, and 5 Research Projects funded by Indian Government Agencies. He is also on the panel of international reviewers for research proposals for Royal Society Grants. He is also serving as a PUBLON ACADEMY MENTOR and a BENTHAM BRAND AMBASSADOR. He has been recognized by the Editors as an OUTSTANDING REVIEWER for RSC Medicinal Chemistry journal (IF 4.1, Q1) and also for BENTHAM PUBLISHER in 2023. His name is recently featured in the list of top 2% scientists (2023) ranked by team of Stanford University, USA and Elsevier.
Nikolajs Sjakste
Experience
1978 -1987; Researcher in the Cancer Cell Chemistry Laboratory, Institute of Experimental and Clinical Medicine, Riga, Latvia.
Professor of Medical Biochemistry and Medical Genetics, University of Latvia, Faculty of Medicine (since 1998). Address: Jelgavas Street 1, Riga LV1004 Latvia. Chief of the Department of Medical Biochemistry (2011).
Leading researcher (since 2011) and Head of the Biochemistry Group, Department of Medicinal Chemistry, Latvian Institute of Organic Synthesis (since 1990).
1995 and 1997 “Red position” of CNRS 1993-1998; Institut Jacques Monod, Université Paris VII, Laboratoire de Biochimie de Différentiation, Paris, France.
Education:
Degree of Doctor of Biological Sciences (Dr. habil.), 1992, Institute of Experimental Medicine, St.-Petersburg, Russia. Degree of Candidate of Biological Sciences (Ph. D.), 1984, Cancer Research Centre, Moscow, Russia. Diploma with Distinction in Medical Biophysics, graduated from the Medico-Biological faculty of the 2nd Moscow Medical Institute, Moscow, Russia, 1978.
Nikolai Slavov
I received my undergraduate education from the Massachusetts Institute of Technology (MIT) in 2004. Then, I pursued doctoral research in the Botstein laboratory at Princeton University, aiming to understand how cells coordinate their growth, gene expression, and metabolism. We discovered a simple mechanism that can account for the growth-rate dependent transcriptional responses across a wide range of growth conditions and growth rates. After defending my dissertation in 2010, I began a postdoctoral project in the van Oudenaarden laboratory at MIT, aiming to understand the Warburg effect, a hallmark of cancer cells characterized by the fermentation of glucose in the presence of enough oxygen to support respiration. This work demonstrated that aerobic glycolysis can reduce the energy demands associated with respiratory metabolism and stress survival and that, contrary to expectations and decades-long assumptions, exponential growth at a constant rate can represent not a single metabolic/physiological state but a continuum of changing states characterized by different metabolic fluxes. Following a lead from these experiments, we obtained direct evidence for differential stoichiometry among core ribosomal proteins in unperturbed wild-type cells. Our findings support the existence of ribosomes with distinct protein composition and physiological function that represent an explored layer of regulating gene expression.
Paula Soares
Professor of Biopathology at Medical Faculty of the University of Porto and coordinator of Cancer Signaling and Metabolism research group at IPATIMUP/I3S.
Kumaravel Somasundaram
Kumar Somasundaram is a Professor at Department of Microbiology Cell Biology, Indian Institute of Science, Bangalore, India. He obtained his Veterinary Medicine degree (1985) from Madras Veterinary College, Masters in Biotechnology (1987) and Ph.D. in bacterial genetics (1993) from Madurai Kamaraj University, Madurai, India. Subsequently, he did his post-doctoral training at Northwestern University and University of Pennsylvania in Cancer Biology before moving to Indian Institute of Science (1999) as a faculty. The major focus of his laboratory is genetics of glioma, the most common primary adult cancer
Jian Song
Since 2016 Dr. Jian Song has been Priv.-Doz of Experimental Immunology within the Institute of Physiological Chemistry and Pathobiochemsitry at the University of Münster, Germany. He received his PhD of Molecular Medicine from Cologne University, Germany.
Dr. Song's research interests include investigating the role of basement membranes and matrix metalloproteinases in leukocyte extravasation into the brain and into the tumour microenvironment using intravital imaging and scRNA technology
Valeria Spagnuolo
Valeria Spagnuolo is Associate Professor in Botany at the Department of Biology at the Federico II University of Naples. She obtained a Ph.D. in molecular systematics (plants) and the scientific qualification to Full Professor 05/A1 (Botany) during the ASN 2018.
Dr. Spagnuolo was involved in several research projects, with a focus on biomonitoring and phytoremediation, within her task/unit and in international teams (the most recent ones: EU Project FP7- ENV.2011.3.1.9-1 Mossclone (2012-15); LIFE11 ENV/IT/275 Ecoremed (2012-2017); PON 03PE_00107. Biopolis (2013-2017).
Dr. Spagnuolo's expertise includes genetic variation in natural populations of mosses along environmental gradients; biomonitoring of air quality by cryptogams and vascular plants; and phytoremediation of metal-polluted soil. In recent years, her long research experience has been centred on plant response to abiotic stresses and biomonitoring of indoor air pollution.
She is involved in editorial activities, as a reviewer for international journals (e.g. Environmental Pollution, Frontiers in Plant Science), as a guest editor in Atmosphere and Plant Journals, and as an editor of the latest Italian edition of Raven (Zanichelli).
Dr. Spagnuolo has published over 60 publications (Scopus ID 6602352988), with an h-index 20 and over 1200 citations. She also detects a patent as the inventor of a tool for biomonitoring of air quality (EP 3 076 171 A1).
Mitchell S Stark
For the past 20 years I have been actively working in the field of melanoma and naevi genomics. I have worked and performed my PhD candidature based at the QIMR Berghofer Medical Research Institute (1999-2015) and in 2015 I relocated as a Research Fellow in the Dermatology Research Centre, The University of Queensland Diamantina Institute. Over this time I have been working towards understanding the aetiology of melanoma, studying gene dysregulation during tumour progression along with predisposition to melanoma in families with high risk for melanoma development. My research group (genomics and miRNA biomarker discovery) based within the Dermatology Research Centre (UQDI) is currently engaged in miRNA biomarker and genomics research for early detection in melanoma, skin cancer (SCC), as well as non-small cell lung cancer.